期刊文献+

血清AFP临界值判断对肝癌诊断的影响 被引量:7

Influence of Cut-off Value of AFP on Diagnosis of Hepatic Cancer
下载PDF
导出
摘要 为探讨血清AFP诊断肝癌的合理临界值,本研究收集肝癌患者35例、正常对照者35例。血清AFP检测采用电化学发光法和酶联免疫吸附法(ELISA)定量,结果用t检验和χ2检验进行统计学分析。2种方法检测血清AFP水平显著相关,相关系数为0.978,检测值无显著性差异,P>0.05。二者ROC曲线下面积分别为0.890、0.880,说明血清AFP水平对肝癌诊断价值较高。按照约登指数最大原则确定血清AFP电化学发光法诊断肝癌的临界值为3.25μg/L,其敏感度为74.3%,特异度为94.3%,准确度为84.3%;ELISA法诊断肝癌的临界值为1.118μg/L,其敏感度为62.9%,特异度为100%,准确度为81.4%。而以目前常规临界值20μg/L来分析,则电化学发光法检测AFP诊断肝癌的敏感度仅为45.7%,特异度100%,准确度72.9%;ELISA法敏感度48.6%,特异度100%,准确度74.3%。因此合理降低临界值可有效提高血清AFP水平对肝癌的诊断价值。 To analyze a reasonable cut-off value of serum AFP in hepatic cancer diagnosis,35 cases of hepatic cancer patients and 35 healthy people were chosen as the samples.Electrochemiluminescence immunoassay(ECLIA)and enzyme-1inked immunosorbent assay(ELISA)are used to collect serum samples and analyze AFP levels.SPSS 18.0software was used for statistical analysis.The correlation coefficient is 0.978,showing the results by ECLIA were significantly correlated to those by ELISA.They had no significant difference,P〉0.05.The area under the ROC curve was 0.890,0.880 respectively by these two methods.The sensitivity,specificity and accuracy were 74.3%,94.3%,84.3%by ECLIA if taking 3.25μg/L as cut-off value and 62.9%,100%,81.4%by ELISA if taking 1.118μg/L as cut-off value.Whereas if taking 20μg/L as cut-off value,the sensitivity and accuracy were only 45.7%,72.9%by ECLIA and 48.6%,74.3% by ELISA.So decreasing cut-off value of serum AFP can improve the diagnosis value of hepatic cancer effectively.
出处 《广西师范大学学报(自然科学版)》 CAS 北大核心 2014年第3期121-124,共4页 Journal of Guangxi Normal University:Natural Science Edition
基金 广西自然科学基金资助项目(2010GXNSFC013023) 国家自然科学基金资助项目(81260328)
关键词 肝癌 AFP 临界值 hepatic cancer AFP cut-off value
  • 相关文献

参考文献13

  • 1PARKIN D M, BRAY F, FERLAY J, et al. Global cancer statistics 2002[J]. CA: A Cancer Journal for Clinicians, 2005, 55(2) :74-108.
  • 2杨秉辉,丛文铭,周晓军,陈孝平,杨甲梅,樊嘉,王建华,杨仁杰,李槐,蒋国梁,曾昭冲,陈敏华,陈敏山,梁萍,吕明德,罗荣城,刘鲁明,秦叔逵,叶胜龙,吴孟超,汤钊猷,孙燕,管忠震.原发性肝癌规范化诊治专家共识[J].临床肿瘤学杂志,2009,14(3):259-269. 被引量:310
  • 3RANDEEP K, ASHOK J, MICHAEl. N, et al. Clinical significance of elevated a-fetoprotein in adults and children [J]. Digestive Diseases and Sciences, 2001, 46(8):1709-1713.
  • 4XU Xiao, KE Qing-hong, SHAO Zhe-xin, et al. The value of serum -fetoprotein in predicting tumor recurrence after liver transplantation for hepatocellular carcinoma[J]. Digestive Diseases and Sciences, 2009, 54(2) :385-388.
  • 5GOSHI S, NORIMASA M. Biomarkers for hepatocellular carcinoma[J]. Clinical Journal of Gastroenterology, 2012, 5 (3) : 177-182.
  • 6HUANG JEE-FU, KENICHI T, SHUICHI O, et al. Primary hepatocellular carcinoma detected long after tumor markers and lymph node metastases beyond our vision? [J]. Digestive Diseases and Sciences, 2006, 51(3) 610-615.
  • 7HU Jin-song, WU De wu, LIANG Shuo, et al. GP73, a resident Golgi glycoprotein, is sensibility and specificity for hepatocellular carcinoma of diagnosis in a hepatitis B-endemic Asian population[J]. Medical Oncology, 2010, 27 (2): 339-345.
  • 8CARMEN A, JORDI R. Imaging of HCC[J]. Abdominal Imaging, 2012, 37(2):215-230.
  • 9CAROI.INE D M W, SUSANNA M van A, EWOUT W S, et al. Recently introduced biomarkers for screening of hepatocellular carcinoma: a systematic review and meta analysis[J]. Hepatology International, 2013, 7 (1) : 59-64.
  • 10HSIA C Y, HUO T I, CHIANG S Y, et al. Evaluation of interleukin-6, interleukin-10 and human hepatocyte growth factor as tumor markers for hepatocellular careinoma[J]. European Journal of Surgical Oncology, 2007, 33 (2) :208-212.

共引文献309

同被引文献61

  • 1邱大鹏,韩风,聂常富,周进学,蒙博.AFP-L3和AFP mRNA联合检测在肝癌治疗疗效观察和预后中的作用[J].中国老年学杂志,2014,34(10):2637-2638. 被引量:6
  • 2赵春玲,宋咏梅,樊飞跃,詹启敏.细胞周期蛋白cyclin B1与肿瘤[J].肿瘤,2007,27(4):322-326. 被引量:17
  • 3许斌(综述),华立新(审校).膀胱癌流行病学进展[J].国际泌尿系统杂志,2007,27(4):469-476. 被引量:14
  • 4Ferlay J, Soerjomataram I, Dikshit R, et al. Cancer inci- dence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012 [J]. Int J Cancer, 2015,136(5) :E359-E386.
  • 5全国肿瘤登记中心全国肿瘤防治研究办公室,卫生部疾病预防控制中心.2012年中国肿瘤登记年报[M].军事医学科学出版社,2012.
  • 6Mpeb C, Hr S, H S. Cancer Incidence in Five Continents, Vol IX[M]. IARC Scientific Publication, 2008.
  • 7Felay L, Burkhard C, Whelan So Check and Conversion Programs for Cancer Registries . IRAC Technical Report No.42.[M]. IRAC, 2005.
  • 8Bray F, Parkin D M. Evaluation of data quality in the can- cer registry: principles and methods. Part I: comparabili- ty, validity and timeliness [J]. Eur J Cancer, 2009,45 (5) : 747-755.
  • 9Parkin DM, Chen VW, Ferlay J. Comparability and Qual- ity Control in Cancer Registration. IRAC Technical Report No.19[M]. IRAC, 1994.
  • 10Marchevsky A M, Nelson V, Martin S E, et al. Telecy- tology of fine-needle aspiration biopsies of the pancreas : a study of well-differentiated adenocareinoma and chronic pancreatitis with atypical epithelial repair changes[J]. Diagn Cytopathol, 2003,28(3): 147-152.

引证文献7

二级引证文献30

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部